Skip to main content

Day: June 5, 2024

NFI Buys Brokerage Business Unit of Transfix

Transfix Enters New Chapter Focused On Software and Data Solutions for Brokers, Shippers, and Carriers, with NFI as Anchor Customer CAMDEN, N.J. and NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) — NFI, a leading supply chain solutions provider, and Transfix, a leading digital freight platform, today announced that NFI has acquired Transfix’s freight brokerage operation. With this, Transfix will pivot its core business to solely focus on powerful software and data solutions for brokers, shippers, and carriers, with NFI set to be the first third-party customer to utilize Transfix’s TMS. The talent and technology the Transfix team brings to NFI will help strengthen carrier and customer interactions and offer more robust brokerage solutions that will be coupled with NFI’s existing in-house technology. In addition, NFI will add over 15,000...

Continue reading

Ingersoll Rand to Participate in Upcoming Investor Conference

DAVIDSON, N.C., June 05, 2024 (GLOBE NEWSWIRE) — Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and industrial solutions, announced that Vik Kini, chief financial officer, and Matthew Fort, vice president, Investor Relations and Corporate FP&A, will participate in a fireside chat at the Wells Fargo 2024 Industrials Conference on Tuesday June 11, 2024, at 9:00 a.m. Eastern Time. A real-time audio webcast of the fireside chat can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website here. A replay of the webcast will be available after conclusion of the fireside chat and can be accessed on the Ingersoll Rand Investor Relations website. About Ingersoll Rand Inc. Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership...

Continue reading

Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024

LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will present at the Sidoti Small Cap Conference, which will take place virtually on June 12, 2024. The Company will present at 10:45 am Eastern Time on Wednesday, June 12, 2024. To join the presentation, please visit the webcast available online at https://investor.assertiotx.com/. Additionally, investors participating in the conference can request a 1×1 meeting via their Sidoti representative, or contact Assertio investor relations via mkreps@darrowir.com. About Assertio Assertio is a commercial pharmaceutical company offering differentiated...

Continue reading

Norwegian Cruise Line Holdings Publishes 2023 “Sail & Sustain” Report Showcasing Progress in Sustainability Initiatives

In addition to underpinning the Company’s “Charting the Course” strategy, the “Sail & Sustain” program reinforces the Company’s commitment to pursue net zero by 2050. Among highlights, the Company achieves key milestone ahead of schedule with 50% of fleet equipped for shore power, targeting 70% by 2025. MIAMI, June 05, 2024 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”), a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands, today published its 2023 “Sail & Sustain” Report, which details the Company’s progress in its global sustainability program, emphasizing the Company’s dedication to driving positive environmental and societal impact. This effort is a cornerstone of the recently unveiled “Charting the Course”...

Continue reading

Ocular Therapeutix® to Host Investor Day on June 13, 2024

Company to highlight corporate strategy, clinical data, and development plans for AXPAXLI™ in wet AMD and NPDR Event to feature prominent retinal disease experts Baruch D. Kuppermann, MD, PhD (University of California, Irvine) and Dilsher S. Dhoot, MD (California Retina Consultants) In-person event with virtual access to take place on June 13, 2024, at 2:00 PM ET BEDFORD, Mass., June 05, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, will host an Investor Day on Thursday, June 13, 2024. The in-person event with...

Continue reading

Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference

COLUMBUS, Ohio, June 05, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending and saving solutions, today announced the company’s participation in the Morgan Stanley U.S. Financials, Payments & CRE Conference on Wednesday, June 12. Bread Financial EVP and Chief Financial Officer Perry Beberman will participate in a fireside chat. The fireside chat will take place at 11 a.m. ET and will be broadcast live here. The fireside chat can also be accessed through Bread Financial’s investor relations website. A replay of the webcast will be available for 90 days following the event. About Bread Financial™Bread Financial™ (NYSE: BFH) is a tech-forward financial services company providing simple, personalized payment,...

Continue reading

Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference

PHILADELPHIA, June 05, 2024 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 4:00 p.m. ET. A live webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement...

Continue reading

Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offshore Construction Contractor

Expands Merrows Offering into Africa MONROE TOWNSHIP, N.J., June 05, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has been awarded a contract for a WAM-V for immediate delivery to an Offshore Construction Contractor. The award includes providing a spare vehicle system that can be assembled onsite. The vehicle will provide survey services for an offshore dredging project in Sub-Saharan Africa. Revenue from this contract will be recognized over the course of the contract. This award builds on the recent commercial success of OPT’s vehicles in offshore construction, and energy industry. Philipp Stratmann, CEO and President of OPT, expressed his enthusiasm about...

Continue reading

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that its Annual Shareholders Meeting will begin at 9:30 a.m. ET. on June 12, 2024, and will be conducted in a virtual format only. Registration for attendees will start at 9:15 a.m. ET. To participate in the Annual Shareholders Meeting, shareholders should visit www.virtualshareholdermeeting.com/INKT2024 and enter the 16-digit control number found in their proxy materials. Guests may also access the meeting in listen-only mode. No control number is required for guests. Webcast Information: Date: Wednesday,...

Continue reading

Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States

Hydreight Technologies is launching this healthcare platform in partnership with VS Digital Health and DSV Global. The platform is called VSDHOne (Read as VSDH-One). VSDHOne Simplifies the entry challenges for companies and medi-spa businesses to enter the Online healthcare space compliantly. DSV global is going to use VS Digital Health and Hydreight’s Technology and infrastructure to help all business to launch a direct to consumer healthcare brand in matter of days in all 50 states. Compliant offerings include: GLP-1s (Semaglutide, Tirzepatide), Peptides, Personalized Healthcare Treatments, Sermorelin, TRT , Hair Loss, Skincare, Sexual Health and more. VSDHOne’s soft release was in May 2024 and the official Launch will be in June with already having a waitlist of potential clients to come onboard.VANCOUVER, British Columbia and LAS...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.